Pediatric Neurology
Volume 31, Issue 5 , Pages 326-332, November 2004

Value of biochemical markers for outcome in term infants with asphyxia

  • Hasan Tekgul, MD

      Affiliations

    • Department of Pediatrics, Division of Pediatric Neurology, Ege University Hospital, Izmir, Turkey
    • Corresponding Author InformationCommunications should be addressed to:Dr. Tekgul; Associate Professor in Pediatrics; Department of Pediatrics; Division of Pediatric Neurology; Ege University Hospital; Bornova-Izmir 35100, Turkey
  • ,
  • Mehmet Yalaz, MD

      Affiliations

    • Department of Pediatrics, Division of Neonatology, Ege University Hospital, Izmir, Turkey
  • ,
  • Necil Kutukculer, MD

      Affiliations

    • Department of Pediatrics, Division of Pediatric Immunology, Ege University Hospital, Izmir, Turkey
  • ,
  • Sureyya Ozbek, MD

      Affiliations

    • Department of Radiology, Ege University Hospital, Izmir, Turkey
  • ,
  • Timur Kose, PhD

      Affiliations

    • Department of Biostatistics, Ege University, Izmir, Turkey
  • ,
  • Mete Akisu, MD

      Affiliations

    • Department of Pediatrics, Division of Neonatology, Ege University Hospital, Izmir, Turkey
  • ,
  • Nilgun Kultursay, MD

      Affiliations

    • Department of Pediatrics, Division of Neonatology, Ege University Hospital, Izmir, Turkey
  • ,
  • Sarenur Gokben, MD

      Affiliations

    • Department of Pediatrics, Division of Pediatric Neurology, Ege University Hospital, Izmir, Turkey

Received 26 February 2004; accepted 10 May 2004.

The aim of this study was to define the predictive values of serum and cerebrospinal fluid concentrations of interleukin-6 and neuron-specific enolase and urinary uric acid/creatinine ratio for outcome in term infants with perinatal asphyxia. All biochemical markers were measured simultaneously within the 24-72 hours of life in 21 infants. The infants were monitored with a standardized neurologic and developmental evaluation protocol over the 2 years of life. The overall outcome at 2 years of age was categorized as “favorable” or “adverse”. According to Sarnat and Sarnat classification, 12 infants had mild encephalopathy and 9 infants had moderate to severe encephalopathy. Seven of 9 (78%) infants with moderate to severe encephalopathy had adverse outcome. However, all infants with mild encephalopathy had favorable outcome. Interleukin-6 and neuron specific enolase levels in cerebrospinal fluid and serum interleukin-6 levels were significantly correlated with the degree of encephalopathy, as well as the outcome. Interleukin-6 in cerebrospinal fluid (cutoff value, 25.9 pg/mL) had the highest predictive value among the biochemical markers. The predictive factors identified in this study should be examined for their ability in a fresh clinical sample in the neonatal intensive care unit before these markers can be applied to the routine clinical of infantswith perinatal asphyxia.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(04)00279-6

doi:10.1016/j.pediatrneurol.2004.05.004

Pediatric Neurology
Volume 31, Issue 5 , Pages 326-332, November 2004